Literature DB >> 22647419

Normal protein anabolic response to hyperaminoacidemia in insulin-resistant patients with lung cancer cachexia.

Aaron Winter1, Jacqueline MacAdams, Stéphanie Chevalier.   

Abstract

BACKGROUND & AIMS: Insulin resistance of protein anabolism has been speculated to underlie the skeletal muscle wasting characteristic of cancer cachexia. We tested whether insulin resistance is present in cachectic lung cancer patients and if a sustained, physiological elevation of amino acids with hyperinsulinemia would compensate for it.
METHODS: Whole-body [(13)C]leucine and [(3)H]glucose kinetics were assessed in 10 male non-small cell lung cancer (NSCLC) patients and 10 healthy matched controls during a euglycemic, hyperinsulinemic clamp under conditions of isoaminoacidemia followed by hyperaminoacidemia.
RESULTS: Postabsorptive glucose and protein kinetics were comparable between groups. Glucose uptake was significantly lower in NSCLC patients during hyperinsulinemia. During concurrent isoaminoacidemia, protein breakdown was suppressed in both, but rates were elevated in NSCLC; rates of synthesis did not change, resulting in reduced net protein balance (synthesis - breakdown) in response to insulin in NSCLC. With subsequent hyperaminoacidemia, synthesis increased significantly with no further change in breakdown, resulting in similar increase in net balance between groups.
CONCLUSIONS: NSCLC patients with moderate cachexia showed considerable insulin resistance of glucose and of whole-body protein anabolism. Their anabolic protein response was stimulated normally by hyperaminoacidemia. Thus, ample provision of amino acids is a feasible strategy to overcome the protein anabolic failure of cancer cachexia.
Copyright © 2012 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22647419     DOI: 10.1016/j.clnu.2012.05.003

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  25 in total

Review 1.  Role of interleukin-6 in cachexia: therapeutic implications.

Authors:  Aditi A Narsale; James A Carson
Journal:  Curr Opin Support Palliat Care       Date:  2014-12       Impact factor: 2.302

2.  Bridging the gap: are animal models consistent with clinical cancer cachexia?

Authors:  Vickie E Baracos
Journal:  Nat Rev Clin Oncol       Date:  2018-02-06       Impact factor: 66.675

3.  High anabolic potential of essential amino acid mixtures in advanced nonsmall cell lung cancer.

Authors:  M P K J Engelen; A M Safar; T Bartter; F Koeman; N E P Deutz
Journal:  Ann Oncol       Date:  2015-06-25       Impact factor: 32.976

4.  Resistance Exercise Trims the Fat and Puts Some Muscle into Cancer Survivorship.

Authors:  Justin C Brown
Journal:  Sports Med       Date:  2021-09-13       Impact factor: 11.136

5.  Prognostic importance of systemic inflammation and insulin resistance in patients with cancer: a prospective multicenter study.

Authors:  Guo-Tian Ruan; Hai-Lun Xie; Yi-Zhen Gong; Yi-Zhong Ge; Qi Zhang; Zi-Wen Wang; Xi Zhang; He-Yang Zhang; Meng Tang; Meng-Meng Song; Xiao-Wei Zhang; Ming Yang; Yong-Bing Chen; Kai-Ying Yu; Li Deng; Kun-Hua Wang; Ming-Hua Cong; Han-Ping Shi
Journal:  BMC Cancer       Date:  2022-06-25       Impact factor: 4.638

Review 6.  Clinical Implications of Sarcopenic Obesity in Cancer.

Authors:  Isabella P Carneiro; Vera C Mazurak; Carla M Prado
Journal:  Curr Oncol Rep       Date:  2016-10       Impact factor: 5.075

Review 7.  Resistance Exercise's Ability to Reverse Cancer-Induced Anabolic Resistance.

Authors:  Ryan N Montalvo; Justin P Hardee; Brandon N VanderVeen; James A Carson
Journal:  Exerc Sport Sci Rev       Date:  2018-10       Impact factor: 6.230

Review 8.  Protein anabolic resistance in cancer: does it really exist?

Authors:  Mariëlle P K J Engelen; Barbara S van der Meij; Nicolaas E P Deutz
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2016-01       Impact factor: 4.294

Review 9.  Altered glucose metabolism and insulin resistance in cancer-induced cachexia: a sweet poison.

Authors:  Tamhida Masi; Bhoomika M Patel
Journal:  Pharmacol Rep       Date:  2020-11-03       Impact factor: 3.024

Review 10.  Sarcopenia versus cancer cachexia: the muscle wasting continuum in healthy and diseased aging.

Authors:  Alexandra Moreira-Pais; Rita Ferreira; Paula A Oliveira; José A Duarte
Journal:  Biogerontology       Date:  2021-07-29       Impact factor: 4.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.